1. Home
  2. FTI vs ILMN Comparison

FTI vs ILMN Comparison

Compare FTI & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TechnipFMC plc

FTI

TechnipFMC plc

N/A

Current Price

$76.48

Market Cap

26.6B

Sector

Industrials

ML Signal

N/A

Logo Illumina Inc.

ILMN

Illumina Inc.

N/A

Current Price

$194.31

Market Cap

26.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FTI
ILMN
Founded
1884
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.6B
26.7B
IPO Year
2016
2000

Fundamental Metrics

Financial Performance
Metric
FTI
ILMN
Price
$76.48
$194.31
Analyst Decision
Buy
Hold
Analyst Count
13
17
Target Price
$65.50
$124.24
AVG Volume (30 Days)
3.8M
1.7M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
0.26%
N/A
EPS Growth
20.42
170.87
EPS
0.64
0.87
Revenue
$9,932,600,000.00
$4,343,000,000.00
Revenue This Year
$8.49
$6.47
Revenue Next Year
$5.53
$5.58
P/E Ratio
$118.78
$226.28
Revenue Growth
9.35
N/A
52 Week Low
$34.27
$88.00
52 Week High
$77.78
$199.14

Technical Indicators

Market Signals
Indicator
FTI
ILMN
Relative Strength Index (RSI) 68.77 63.70
Support Level $69.25 $116.54
Resistance Level $77.78 $196.66
Average True Range (ATR) 1.98 6.99
MACD 0.68 -0.52
Stochastic Oscillator 89.73 84.36

Price Performance

Historical Comparison
FTI
ILMN

About FTI TechnipFMC plc

TechnipFMC PLC is the key provider of offshore oilfield services, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea construction services. The company also provides various pieces of surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of Technip and FMC Technologies. Geographically it operates in Latin America generating the maximum revenue, then Europe and Central Asia, Africa, North America, Asia Pacific and Middle East.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: